TP53 and neoplasm: For example, Su et al. discovered that the potentiation of TRAIL- and TNFα-induced tumor cell apoptosis by AICAR (an AMPK-specific agonist) is dependent on AMPK and p53 and involves various aspects of apoptotic pathways12.